CymitQuimica logo

CAS 722533-56-4

:

Elacestrant

Description:
Elacestrant, with the CAS number 722533-56-4, is a selective estrogen receptor degrader (SERD) that is primarily investigated for its potential in treating estrogen receptor-positive breast cancer. It functions by binding to the estrogen receptor, leading to its degradation and thereby inhibiting estrogen-driven tumor growth. Elacestrant is characterized by its ability to selectively target and modulate estrogen receptor activity, which distinguishes it from traditional anti-estrogens. The compound is typically administered orally and has been studied in clinical trials for its efficacy and safety profile in patients with advanced breast cancer. Its chemical structure includes specific functional groups that contribute to its activity and pharmacokinetics. As a SERD, Elacestrant represents a novel therapeutic approach, particularly for patients who have developed resistance to conventional endocrine therapies. Ongoing research continues to evaluate its role in combination therapies and its long-term effects on patient outcomes.
Formula:C30H38N2O2
InChI:InChI=1S/C30H38N2O2/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26/h6-9,12-15,19-20,26,31,33H,4-5,10-11,16-18,21H2,1-3H3/t26-/m1/s1
InChI key:SIFNOOUKXBRGGB-AREMUKBSSA-N
SMILES:CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)[C@@H]3CCC4=C(C3)C=CC(=C4)O
Synonyms:
  • 2-Naphthalenol, 6-[2-[ethyl[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydro-, (6R)-
Found 6 products.